$SNOA
Sonoma Pharmaceuticals, Inc. Stock $snoa

$snoa Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000168316822005558 Filed on August 11, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$3.331M	$3.983M	$2.298M
YoY Change	-11.03%	8.12%	6.54%
Cost Of Revenue	$1.995M	$2.537M	$2.222M
YoY Change	-20.49%	13.72%	-7.3%
Gross Profit	$1.336M	$1.446M	$76.00K
YoY Change	8.18%	-0.48%	-131.67%
Gross Profit Margin	40.11%	36.3%	3.31%
Selling, General & Admin	$2.067M	$2.295M	$3.152M
YoY Change	-5.83%	0.97%	26.59%
% of Gross Profit	154.72%	158.71%	4147.37%
Research & Development	$0.00	$6.000K	$4.000K
YoY Change	-100.0%	-92.86%	-96.92%
% of Gross Profit	0.0%	0.41%	5.26%
Depreciation & Amortization	$28.00K	$31.00K	$49.00K
YoY Change	-46.15%	-35.42%	32.43%
% of Gross Profit	2.1%	2.14%	64.47%
Operating Expenses	$2.067M	$2.301M	$3.156M
YoY Change	-6.26%	-2.38%	20.46%
Operating Profit	-$731.0K	-$855.0K	-$3.080M
YoY Change	-24.64%	-5.42%	7.69%
Interest Expense	$3.000K	$0.00	-$9.000K
YoY Change	-175.0%	-100.0%	-550.0%
% of Operating Profit
Other Income/Expense, Net	-$189.0K	-$67.00K	-$936.0K
YoY Change	-126.14%	-65.28%	-1106.45%
Pretax Income	-$917.0K	-$922.0K	-$3.282M
YoY Change	865.26%	-16.03%	20.71%
Income Tax	$100.0K	-$35.00K	-$338.0K
% Of Pretax Income
Net Earnings	-$1.017M	-$887.0K	-$2.944M
YoY Change	917.0%	-19.22%	-19.56%
Net Earnings / Revenue	-30.53%	-22.27%	-128.11%
Basic Earnings Per Share	-$0.33	-$0.29
Diluted Earnings Per Share	-$0.33	-$0.29	-$952.4K
COMMON SHARES
Basic Shares Outstanding	3.101M shares	3.101M shares
Diluted Shares Outstanding	3.101K shares	3.101M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.351M	$5.586M	$7.396M
YoY Change	-60.07%	98.72%	75.26%
Cash & Equivalents	$3.351M	$5.586M	$7.396M
Short-Term Investments
Other Short-Term Assets	$3.530M	$4.009M	$3.964M
YoY Change	-5.39%	7.54%	15.67%
Inventory	$3.025M	$2.788M	$2.663M
Prepaid Expenses
Receivables	$2.487M	$2.434M	$2.407M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$12.39M	$14.82M	$16.43M
YoY Change	-31.23%	21.88%	26.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$305.0K	$309.0K	$320.0K
YoY Change	-70.59%	-71.78%	-71.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$238.0K	$112.0K	$77.00K
YoY Change	-69.09%	-87.11%	-91.2%
Total Long-Term Assets	$2.569M	$2.341M	$2.415M
YoY Change	42.17%	19.2%	20.51%
TOTAL ASSETS
Total Short-Term Assets	$12.39M	$14.82M	$16.43M
Total Long-Term Assets	$2.569M	$2.341M	$2.415M
Total Assets	$14.96M	$17.16M	$18.85M
YoY Change	-24.54%	21.51%	25.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.074M	$2.057M	$1.641M
YoY Change	-42.75%	12.34%	-7.24%
Accrued Expenses	$2.071M	$2.185M	$2.093M
YoY Change	63.97%	50.07%	50.14%
Deferred Revenue
YoY Change
Short-Term Debt	$229.0K	$459.0K	$688.0K
YoY Change	15.08%	15.62%
Long-Term Debt Due	$0.00	$0.00	$120.0K
YoY Change	-100.0%	-100.0%	-79.87%
Total Short-Term Liabilities	$3.527M	$4.854M	$5.819M
YoY Change	-13.51%	-7.24%	42.69%
LONG-TERM LIABILITIES
Long-Term Debt	$15.00K	$15.00K	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$4.399M	$4.330M	$4.329M
YoY Change	2.54%	1.48%	2.2%
Total Long-Term Liabilities	$15.00K	$15.00K	$0.00
YoY Change	-99.65%	-99.65%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.527M	$4.854M	$5.819M
Total Long-Term Liabilities	$15.00K	$15.00K	$0.00
Total Liabilities	$7.941M	$9.199M	$10.15M
YoY Change	-5.1%	-3.17%	5.44%
SHAREHOLDERS EQUITY
Retained Earnings	-$186.3M	-$185.3M	-$184.4M
YoY Change
Common Stock	$197.7M	$197.6M	$197.4M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.021M	$7.959M	$8.697M
YoY Change
Total Liabilities & Shareholders Equity	$14.96M	$17.16M	$18.85M
YoY Change	-24.54%	21.51%	25.74%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$1.017M	-$887.0K	-$2.944M
YoY Change	917.0%	-19.22%	-19.56%
Depreciation, Depletion And Amortization	$28.00K	$31.00K	$49.00K
YoY Change	-46.15%	-35.42%	32.43%
Cash From Operating Activities	-$1.830M	-$1.533M	-$1.395M
YoY Change	40.34%	25.35%	-5.62%
INVESTING ACTIVITIES
Capital Expenditures	-$25.00K	$23.00K	-$62.00K
YoY Change	0.0%	-53.06%	588.89%
Acquisitions
YoY Change
Other Investing Activities	-$162.0K		$1.000K
YoY Change	-550.0%		-133.33%
Cash From Investing Activities	-$187.0K	-$23.00K	-$61.00K
YoY Change	-1800.0%	-53.06%	2950.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-178.0K	-$387.0K	222.0K
YoY Change	-102.57%	85.17%	-17.16%
NET CHANGE
Cash From Operating Activities	-1.830M	-$1.533M	-1.395M
Cash From Investing Activities	-187.0K	-$23.00K	-61.00K
Cash From Financing Activities	-178.0K	-$387.0K	222.0K
Net Change In Cash	-2.195M	-$1.810M	-1.234M
YoY Change	-139.01%	28.46%	1.82%
FREE CASH FLOW
Cash From Operating Activities	-$1.830M	-$1.533M	-$1.395M
Capital Expenditures	-$25.00K	$23.00K	-$62.00K
Free Cash Flow	-$1.805M	-$1.556M	-$1.333M
YoY Change	41.13%	22.33%	-9.26%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001367083
CY2022Q2	dei	Amendment Flag AmendmentFlag	false
CY2022Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2022Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q2	dei	Document Type DocumentType	10-Q
CY2022Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q2	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
CY2022Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q2	dei	Entity File Number EntityFileNumber	001-33216
CY2022Q2	dei	Entity Registrant Name EntityRegistrantName	SONOMA PHARMACEUTICALS, INC
CY2022Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	68-0423298
CY2022Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	645 Molly Lane
CY2022Q2	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 150
CY2022Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Woodstock
CY2022Q2	dei	Entity Address Country EntityAddressCountry	GA
CY2022Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30189
CY2022Q2	dei	City Area Code CityAreaCode	(800)
CY2022Q2	dei	Local Phone Number LocalPhoneNumber	759-9305
CY2022Q2	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value
CY2022Q2	dei	Trading Symbol TradingSymbol	SNOA
CY2022Q2	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q2	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q2	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q2	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3100937	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5586000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7396000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2434000	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2407000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	2788000	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	2663000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3794000	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3746000	usd
CY2022Q2	SNOA	Deferred Consideration Net Current DeferredConsiderationNetCurrent	215000	usd
CY2022Q1	SNOA	Deferred Consideration Net Current DeferredConsiderationNetCurrent	218000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	14817000	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	16430000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	309000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	320000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	478000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	559000	usd
CY2022Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	859000	usd
CY2022Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	829000	usd
CY2022Q2	SNOA	Deferred Consideration Net Noncurrent DeferredConsiderationNetNoncurrent	583000	usd
CY2022Q1	SNOA	Deferred Consideration Net Noncurrent DeferredConsiderationNetNoncurrent	630000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	112000	usd
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	77000	usd
CY2022Q2	us-gaap	Assets Assets	17158000	usd
CY2022Q1	us-gaap	Assets Assets	18845000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2057000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-904000	usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1641000	usd
CY2022Q2	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	1952000	usd
CY2022Q1	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	1843000	usd
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	100000	usd
CY2022Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1223000	usd
CY2022Q2	SNOA	Contract With Customer Liability Current Invekra ContractWithCustomerLiabilityCurrentInvekra	53000	usd
CY2022Q1	SNOA	Contract With Customer Liability Current Invekra ContractWithCustomerLiabilityCurrentInvekra	54000	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2022Q1	us-gaap	Notes Payable Current NotesPayableCurrent	120000	usd
CY2022Q2	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	459000	usd
CY2022Q1	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	688000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	233000	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	250000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4854000	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5819000	usd
CY2022Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	152000	usd
CY2022Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	182000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	15000	usd
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2022Q2	SNOA	Withholding Tax Payable WithholdingTaxPayable	3933000	usd
CY2022Q1	SNOA	Withholding Tax Payable WithholdingTaxPayable	3838000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	245000	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	309000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	9199000	usd
CY2022Q1	us-gaap	Liabilities Liabilities	10148000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	24000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	24000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3100937	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3100937	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3100937	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3100937	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	2000	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	2000	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	197584000	usd
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	197370000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-185250000	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-184363000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4377000	usd
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4312000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-922000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1098000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-35000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	7959000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	8697000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17158000	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18845000	usd
CY2022Q2	us-gaap	Revenues Revenues	3983000	usd
CY2021Q2	us-gaap	Revenues Revenues	3684000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2537000	usd
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2231000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	1446000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	1453000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	84000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2295000	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2273000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	2301000	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	0	usd
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1000	usd
CY2022Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-67000	usd
CY2021Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-193000	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	2357000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-855000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-887000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1098000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.52
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.52
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3101000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2093000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3101000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2093000	shares
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-887000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1098000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-65000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	307000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-952000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-791000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-887000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1098000	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	31000	usd
CY2021Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	48000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	214000	usd
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	59000	usd
CY2022Q2	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	40000	usd
CY2021Q2	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-0	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	73000	usd
CY2021Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	112000	usd
CY2022Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	175000	usd
CY2021Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9000	usd
CY2022Q2	SNOA	Increase Decrease In Deferred Consideration Net Of Discount IncreaseDecreaseInDeferredConsiderationNetOfDiscount	41000	usd
CY2021Q2	SNOA	Increase Decrease In Deferred Consideration Net Of Discount IncreaseDecreaseInDeferredConsiderationNetOfDiscount	39000	usd
CY2022Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	76000	usd
CY2021Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	214000	usd
CY2022Q2	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-31000	usd
CY2021Q2	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-67000	usd
CY2022Q2	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	423000	usd
CY2021Q2	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	28000	usd
CY2022Q2	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	114000	usd
CY2021Q2	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	40000	usd
CY2022Q2	SNOA	Increase Decrease In Withholding Tax Payable IncreaseDecreaseInWithholdingTaxPayable	95000	usd
CY2021Q2	SNOA	Increase Decrease In Withholding Tax Payable IncreaseDecreaseInWithholdingTaxPayable	92000	usd
CY2022Q2	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-94000	usd
CY2021Q2	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-66000	usd
CY2022Q2	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1137000	usd
CY2021Q2	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-97000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1533000	usd
CY2021Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1223000	usd
CY2022Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23000	usd
CY2021Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	49000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-23000	usd
CY2021Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-49000	usd
CY2022Q2	SNOA	Payment On Atm Agreement Offering PaymentOnAtmAgreementOffering	-0	usd
CY2021Q2	SNOA	Payment On Atm Agreement Offering PaymentOnAtmAgreementOffering	10000	usd
CY2022Q2	SNOA	Principal Payments On Ppp Loan PrincipalPaymentsOnPppLoan	120000	usd
CY2021Q2	SNOA	Principal Payments On Ppp Loan PrincipalPaymentsOnPppLoan	-0	usd
CY2022Q2	us-gaap	Payments For Other Deposits PaymentsForOtherDeposits	37000	usd
CY2022Q2	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	230000	usd
CY2021Q2	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	199000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-387000	usd
CY2021Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-209000	usd
CY2022Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	133000	usd
CY2021Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	72000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1810000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1409000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7396000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4220000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5586000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2811000	usd
CY2022Q2	us-gaap	Interest Paid Net InterestPaidNet	4000	usd
CY2021Q2	us-gaap	Interest Paid Net InterestPaidNet	4000	usd
CY2022Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	55000	usd
CY2021Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	8697000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	214000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-65000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-887000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	7959000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	5363000	usd
CY2021Q2	SNOA	Transaction Costs Related To Atm Agreement Offering TransactionCostsRelatedToAtmAgreementOffering	-10000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	56000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	3000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	307000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1098000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	4621000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-887000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-185250000	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-184363000	usd
CY2022Q2	SNOA	Working Capital WorkingCapital	9963000	usd
CY2022Q1	SNOA	Working Capital WorkingCapital	10611000	usd
CY2022Q2	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_zQFGVVdhsA5a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_861_zRvVCK1H4SRd">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent liabilities at the dates of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from these estimates. Significant estimates and assumptions include reserves and write-downs related to receivables and inventories, the recoverability of long-lived assets, the valuation allowance relating to the Company’s deferred tax assets, valuation of equity and derivative instruments, and the estimated amortization periods of upfront product licensing fees received from customers. Periodically, the Company evaluates and adjusts estimates accordingly.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt"> </p>
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-887000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1098000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3101000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2093000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3101000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2093000	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.52
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	536000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	58000	usd
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.52
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	602000	shares
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	420000	shares
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q2	SNOA	Allowance For Sales Discounts Rebates Distributor Fees And Returns AllowanceForSalesDiscountsRebatesDistributorFeesAndReturns	81000	usd
CY2022Q1	SNOA	Allowance For Sales Discounts Rebates Distributor Fees And Returns AllowanceForSalesDiscountsRebatesDistributorFeesAndReturns	81000	usd
CY2022Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	217000	usd
CY2022Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	218000	usd
CY2022Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1612000	usd
CY2022Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1626000	usd
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1176000	usd
CY2022Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1037000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	2788000	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	2663000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	478000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	559000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	233000	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	250000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	245000	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	309000	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	94000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	31000	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P25M9D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0600	pure
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	210000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	208000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	104000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	14000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	478000	usd
CY2022Q2	us-gaap	Salaries And Wages SalariesAndWages	775000	usd
CY2022Q2	us-gaap	Severance Costs1 SeveranceCosts1	775000	usd
CY2022Q2	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	723000	usd
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	24000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	214000	usd
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	59000	usd
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0408	pure
CY2022Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3983000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3684000	usd

Files In Submission

Name	View Source	Status
snoa-20220630_cal.xml	Edgar Link	unprocessable
0001683168-22-005558-index-headers.html	Edgar Link	pending
0001683168-22-005558-index.html	Edgar Link	pending
0001683168-22-005558.txt	Edgar Link	pending
0001683168-22-005558-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
snoa-20220630.xsd	Edgar Link	pending
sonoma_ex3101.htm	Edgar Link	pending
sonoma_ex3102.htm	Edgar Link	pending
sonoma_ex3201.htm	Edgar Link	pending
sonoma_i10q-063022.htm	Edgar Link	pending
snoa-20220630_def.xml	Edgar Link	unprocessable
snoa-20220630_pre.xml	Edgar Link	unprocessable
snoa-20220630_lab.xml	Edgar Link	unprocessable
sonoma_i10q-063022_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SNOA
Sonoma Pharmaceuticals, Inc. Stock $snoa

2022 Q3 Form 10-Q Financial Statement

#000168316822005558 Filed on August 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SNOA Sonoma Pharmaceuticals, Inc. Stock $snoa

2022 Q3 Form 10-Q Financial Statement

#000168316822005558 Filed on August 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SNOA
Sonoma Pharmaceuticals, Inc. Stock $snoa